Company
Headquarters: Osborne Park, WA, Australia
Employees: 25
CEO: Mr. Michael Dean Vegar
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $37.81 B |
| Veeva Systems Inc. | $36.08 B |
| M3, Inc. | $11.14 B |
| Change Healthcare Inc. | $9.03 B |
| Pro Medicus Limited | $8.96 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
HitIQ Limited develops and commercializes concussion management technology in Australia. The company offers Nexus A9 sensor to record individual head impacts. Its Nexus software delivers a platform for measuring and managing head impact exposures, as well as allows users to quantify exposures across individual players, positions, periods, and drills. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform which identifies impairments across domains, such as hand-eye coordination, memory, and decision making. HitIQ Limited was incorporated in 2015 and is based in Melbourne, Australia.
HitIQ Ltd has the following listings and related stock indices.
Stock: ASX: HIQ wb_incandescent